ALK and lung adenocarcinoma: Moreover, the research have indicated that patients with ALK rearrangements are particularly susceptible to developing brain metastases, with an incidence as high as 66% in ALK-positive (ALK+) patients, whereas the overall incidence in all lung adenocarcinoma cases is lower (7).